The Claim
Multivariate analysis of 22 biomarkers in hospitalized COVID-19 patients did not identify a consistent pattern or biomarker profile that reliably predicts disease severity.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Analysis of 22 biomarkers in hospitalized COVID-19 patients found no consistent pattern that reliably indicates how severe the disease will become.
See the scientific wording
Multivariate analysis of 22 biomarkers in hospitalized COVID-19 patients failed to identify a consistent pattern or biomarker profile that reliably predicts disease severity, highlighting the complex, multifactorial nature of clinical outcomes.
When there is more EPA than AA in the blood, it replaces AA in cell membranes, which reduces the production of inflammatory signals and harmful oxidative byproducts. This lowers the levels of key inflammatory proteins and oxidative damage markers, making it less likely for the body to spiral into severe illness.
What the research says
1 studyStudy: The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids
Scientists looked at many blood markers in sick COVID patients and found that while one specific ratio (EPA to AA) was linked to worse illness, no combination of markers reliably predicted how sick someone would get—showing the disease is too complex for a simple test.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.